Sidra Medicine Publishes Groundbreaking study on Pediatric Cancer Tumors QF Entity study highlights precision medicine approach to guide treatment for certain childhood cancers 21 September 2022, Doha, Qatar – Researchers from Human Immunology in collaboration with the … Continue Reading.....

Sidra Medicine Gene Therapy Program Saves Lives QF Entity Appointed as Lead Treatment Center in MENA to administer life-saving SMA drug for babies 14 September 2022, Doha, Qatar – The Genetics and Genomic division at Sidra Medicine has launched … Continue Reading.....

Sidra Medicine on the World Stage at PICS QF Entity pioneering interventional valve implantation shared as successful methodology to treat CHD patients 11 September 2022, Doha, Qatar – Sidra Medicine has showcased its latest surgical and c… Continue Reading.....

Sidra Medicine and Qatar Cancer Society Partner to Mark Childhood Cancer Awareness Month in September Sidra Medicine and Qatar Cancer Society have partnered to mark Childhood Cancer Awareness Month in Qatar with a host of collaborative activities to support children with cancer and their families. A s… Continue Reading.....

Sidra Medicine to host Pediatric Neuroscience Conference QF Entity partners with the Society for Research into Hydrocephalus and Spina Bifida 16 August 2022, Doha, Qatar – Sidra Medicine will host its second Pediatric Neuroscience Conference (PNC 2022) f… Continue Reading.....

Sidra Medicine to host Precision Medicine Functional Genomics (PMFG) Symposium QF Entity symposium to focus on how personalized medicine can move from vision to practice Sidra Medicine will host its eighth annual Precision Medicine Functional Genomics (PMFG) Symposium from 23… Continue Reading.....